Cost-Effectiveness of Full Medicare Coverage of Angiotensin-Converting Enzyme Inhibitors for Beneficiaries With DiabetesRosen AB, Hamel MB, Weinstein MC, et al (Univ of Michigan, Ann Arbor; Harvard School of Public Health, Boston; Harvard Univ, Cambridge, Mass) Ann Intern Med 143:89-99, 2005§
暂无分享,去创建一个
J. Drazen | C. Tanner | W. Pryor | C. Laine | A. Marušić | F. Frizelle | W. Elliott | A. Overbeke | J. Hoey | R. Horton | S. Kotzin | K. Krishnan | S. Campbell | C. Angelis | Abraham Spence | Charlotte Haug | Torben | V. Schroeder | Chengjie Xiong | Kevin Douglas